The Boston Course in Obesity Medicine 2023
The Boston Course in Obesity Medicine is a comprehensive educational video program designed to explore current scientific principles in obesity medicine. This program delivers structured learning through expert-led presentations, making it an effective academic resource for healthcare learners, clinicians, and allied health professionals.
This course provides foundational and advanced perspectives on obesity-related biology, clinical frameworks, and management concepts — all presented for educational and professional reference.
Why Choose This Course
This program offers a clear and structured learning experience with content developed by experienced educators in the field of obesity science and medicine:
- Organized, easy-to-follow video modules
- Evidence-informed content for professional learning
- Balanced exploration of biologic and clinical concepts
- Designed for self-paced study on any device
What You’ll Learn
The curriculum includes educational discussions that help learners understand:
- Biological mechanisms related to energy balance and adiposity
- Key principles of metabolic regulation and endocrine influences
- Exercise science and its role in health and wellness
- Clinical considerations in obesity-related physiology
- Concepts underlying patient-centered care approaches
- Contextual frameworks used in obesity medicine education
key Highlights:
- This year’s course presents a dynamic platform for engaging with the latest advancements in obesity science and clinical care. Noteworthy highlights include:
- Trailblazing Research and Studies: Discussions will encompass significant studies and reports, such as the “SURMOUNT-1” phase 3 study that demonstrated remarkable weight loss of up to 22% through tirzepatide treatment for obesity.
- Adolescent Obesity Treatment Breakthroughs: Insights will be shared regarding the “STEP TEENS” study, revealing the efficacy of semaglutide 2.4 mg weekly in achieving an average weight loss of 17% among adolescents, culminating in FDA approval.
- Guideline Updates: Participants will delve into the latest “American Academy of Pediatrics clinical practice guidelines” for treating obesity in children and adolescents, as well as “Canadian clinical practice guidelines” for obesity evaluation and management.
- Medical Advancements: The course will explore ground-breaking research, such as the SELECT study’s investigation into semaglutide 2.4 mg weekly’s impact on cardiovascular outcomes and the resolution of NASH with resmetirom.
- Multimodal Treatment Approaches: Attendees will gain insights into effective multimodal treatment strategies, endoscopic approaches, and the unique benefits of combination therapies.
- Equitable Access and Reimbursement: Discussions will shed light on collaborative initiatives aimed at improving patient access to effective obesity care and garnering greater attention from payers and policymakers.
Access & Convenience
- On-Demand Access
- Compatible with desktop, tablet, and mobile devices
- No physical materials or subscriptions required
Who Will Benefit
This educational program is ideal for:
- Medical and health sciences students
- Physicians, nurses, and allied health professionals
- Researchers and educators seeking updated academic perspectives
- Clinicians pursuing structured professional learning
Educational & Reference Use Only
This course is provided for educational and professional learning purposes.
It does not provide medical advice, diagnosis, or treatment recommendations and should not be used as a substitute for clinical judgment.
